Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to evaluate whether procalcitonin was superior to C-reactive protein in guiding antibiotic therapy in intensive care patients with sepsis. DESIGN: Randomized open clinical trial. SETTING: Two university hospitals in Brazil. PATIENTS: Patients with severe sepsis or septic shock. INTERVENTIONS: Patients were randomized in two groups: the procalcitonin group and the C-reactive protein group. Antibiotic therapy was discontinued following a protocol based on serum levels of these markers, according to the allocation group. The procalcitonin group was considered superior if the duration of antibiotic therapy was at least 25% shorter than in the C-reactive protein group. For both groups, at least seven full-days of antibiotic therapy were ensured in patients with Sequential Organ Failure Assessment greater than 10 and/or bacteremia at inclusion, and patients with evident resolution of the infectious process had antibiotics stopped after 7 days, despite biomarkers levels. MEASUREMENTS AND MAIN RESULTS: Ninety-four patients were randomized: 49 patients to the procalcitonin group and 45 patients to the C-reactive protein group. The mean age was 59.8 (SD, 16.8) years. The median duration of antibiotic therapy for the first episode of infection was 7.0 (Q1-Q3, 6.0-8.5) days in the procalcitonin group and 6.0 (Q1-Q3, 5.0-7.0) days in the C-reactive protein group (p=0.13), with a hazard ratio of 1.206 (95% CI, 0.774-1.3; p=0.13). Overall, protocol overruling occurred in only 13 (13.8%) patients. Twenty-one patients died in each group (p=0.836). CONCLUSIONS: C-reactive protein was as useful as procalcitonin in reducing antibiotic use in a predominantly medical population of septic patients, causing no apparent harm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“The early and empirical initiation of antibiotic treatment is recommended for patients with suspected severe bacterial infection and is associated with lower mortality (2, 3).”
Background2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“The inclusion of the SOFA score sought to increase patient safety (39).”
BackgroundBouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Self-citationPrina, E., Ranzani, O. T., & Torres, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60733-4 · Cited by 516
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30592-3 · Cited by 486
Self-citation2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., Salluh, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06956-y · Cited by 292
Wirz, Y., Meier, M. A., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Schroeder, S., Nobre, V., Annane, D., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2125-7 · Cited by 265
Self-citationvon Dach, E., Albrich, W. C., Brunel, A.-S., Prendki, V., Cuvelier, C., Flury, D., Gayet-Ageron, A., Huttner, B., Kohler, P., Lemmenmeier, E., et al. (2020) · JAMA · doi:10.1001/jama.2020.6348 · Cited by 259
“Presence of removable urethral catheter 17 (10) 7 (4) 24 (14)”
BackgroundThe Clinical Challenge of Sepsis Identification and Monitoring
Vincent, J.-L. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002022 · Cited by 259
“A progressive decline in CRP or PCT concentrations can be used to guide earlier discontinuation of antibiotic therapy, without major risks [42].”
BackgroundEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Clinical Utility and Measurement of Procalcitonin.
Samsudin, I. N., & Vasikaran, S. D. (2017) · Europe PMC (PubMed Central) · Cited by 313
Sepsis Biomarkers: Advancements and Clinical Applications—A Narrative Review
He, R., Yue, G.-L., Dong, M.-L., Wang, J., & Cheng, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169010 · Cited by 217
Hamade, B., & Huang, D. T. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.003 · Cited by 160
Dijck, C. V., Vlieghe, E., & Cox, J. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.203448 · Cited by 164
Westwood, M., Ramaekers, B., Whiting, P., Tomini, F., Joore, M., Armstrong, N., Ryder, S., Stirk, L., Severens, J., & Kleijnen, J. (2015) · Health Technology Assessment · doi:10.3310/hta19960 · Cited by 138
Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults
Pepper, D. J., Sun, J., Rhee, C., Welsh, J. A., Powers, J. H., Danner, R. L., & Kadri, S. S. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.029 · Cited by 154
Advances in antibiotic therapy in the critically ill
Vincent, J.-L., Bassetti, M., François, B., Karam, G., Chastre, J., Torres, A., Roberts, J. A., Taccone, F. S., Rello, J., Calandra, T., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1285-6 · Cited by 127
An approach to antibiotic treatment in patients with sepsis
Martínez, M. L., Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.47 · Cited by 135
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection
Ticinesi, A., Lauretani, F., Nouvenne, A., Porro, E., Fanelli, G. C., Maggio, M. G., & Meschi, T. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.08.026 · Cited by 113
Andriolo, B. N., Andriolo, R. B., Salomão, R., & Atallah, Á. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010959.pub2 · Cited by 115
Albrich, W. C., & Harbarth, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3978-8 · Cited by 105
Yang, Y., Xie, J., Guo, F., Longhini, F., Gao, Z., Huang, Y., & Qiu, H. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0153-5 · Cited by 96
Lam, S. W., Bauer, S. R., Fowler, R., & Duggal, A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002953 · Cited by 95
Ryu, J.-A., Yang, J. H., Lee, D.-S., Park, C.-M., Suh, G. Y., Jeon, K., Cho, J., Baek, S. Y., Carriere, K. C., & Chung, C. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138150 · Cited by 88
Biomarker-guided antibiotic therapy—strengths and limitations
Nora, D. G., Salluh, J. I., Martín‐Loeches, I., & Póvoa, P. M. S. R. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.04 · Cited by 96
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
The Captain Study Group, Parlato, M., Philippart, F., Rouquette, A., Moucadel, V., Puchois, V., Blein, S., Bedos, J.-P., Diehl, J.-L., Hamzaoui, O., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5228-3 · Cited by 85
Azzini, A. M., Dorizzi, R. M., Sette, P., Vecchi, M., Coledan, I., Righi, E., & Tacconelli, E. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1855 · Cited by 90
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Use of C-reactive protein to tailor antibiotic use: a systematic review and meta-analysis
Petel, D. S., Winters, N., Gore, G. C., Papenburg, J., Beltempo, M., Lacroix, J., & Fontela, P. S. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022133 · Cited by 82
Duration of antibiotic therapy in the intensive care unit
Zilahi, G., McMahon, A., Póvoa, P. M. S. R., & Martín‐Loeches, I. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.89 · Cited by 83
Papp, M., Kiss, N., Baka, M., Trásy, D., Zubek, L., Fehérvári, P., Harnos, A., Turan, C., Hegyi, P. J., & Molnár, Z. (2023) · Critical Care · doi:10.1186/s13054-023-04677-2 · Cited by 89
Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms
Méndez, R., Menéndez, R., Cillóniz, C., Amara‐Elori, I., Amaro, R., González, P., Posadas, T., Gimeno, A., España, P. P., Almirall, J., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1908oc · Cited by 67
Zaki, H. A., Bensliman, S., Bashir, K., Iftikhar, H., Fayed, M. H., Salem, W., Elmoheen, A. M., & Yiğit, Y. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02432-w · Cited by 66
Sartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 77
Schüetz, P., Bolliger, R., Merker, M., Christ‐Crain, M., Stolz, D., Tamm, M., Luyt, C. E., Wolff, M., Schröder, S., Junior, V. A. N., et al. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1496331 · Cited by 63
Bragança, R. D., Ravetti, C. G., Barreto, L. M., Ataíde, T. B. L. S., Carneiro, R. M., Teixeira, A. L., & Junior, V. A. N. (2019) · Heart & Lung · doi:10.1016/j.hrtlng.2019.07.001 · Cited by 66
AACC Guidance Document on the Clinical Use of Procalcitonin
Chambliss, A. B., Patel, K., Colón-Franco, J. M., Hayden, J. A., Katz, S. E., Minejima, E., & Woodworth, A. L. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfad007 · Cited by 64
Individualising Therapy to Minimize Bacterial Multidrug Resistance
Heffernan, A. J., Sime, F. B., Lipman, J., & Roberts, J. A. (2018) · Drugs · doi:10.1007/s40265-018-0891-9 · Cited by 63
Gong, T., Zhang, X., Peng, Z., Ye, Y., Liu, R., Yang, Y., Chen, Z., Zhang, Z., Hu, H., Yin, S., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03481-y · Cited by 60
Saxena, J., Das, S., Kumar, A., Sharma, A., Sharma, L. K., Kaushik, S., Srivastava, V. K., Siddiqui, A. J., & Jyoti, A. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119891 · Cited by 60
Sartelli, M., Barie, P. S., Agnoletti, V., Al‐Hasan, M. N., Ansaloni, L., Biffl, W. L., Buonomo, L. A., Blot, S. I., Cheadle, W. G., Coimbra, R. S. M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00552-9 · Cited by 68
Use of procalcitonin for the prediction and treatment of acute bacterial infection in children
Pierce, R. W., Bigham, M. T., & Giuliano, J. S. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000092 · Cited by 54
A proposal for a comprehensive approach to infections across the surgical pathway
Sartelli, M., Pagani, L., Iannazzo, S., Moro, M. L., Viale, P., Pan, A., Ansaloni, L., Coccolini, F., D’Errico, M. M., Agreiter, I., et al. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00295-3 · Cited by 65
Peng, F., Chang, W., Xie, J.-F., Sun, Q., Qiu, H.-B., & Yang, Y. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.05.034 · Cited by 49
Intensiva, O. B. O. N. –. N. I. D. I. E. M., Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L. N. A., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C. G., et al. (2020) · Critical Care · doi:10.1186/s13054-020-02946-y · Cited by 53
Self-citationThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology
Bassetti, M., Russo, A., Righi, E., Dolso, E., Merelli, M., D’Aurizio, F., Sartor, A., & Curcio, F. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1562335 · Cited by 45
Kubo, K., Sakuraya, M., Sugimoto, H., Takahashi, N., Kano, K., Yoshimura, J., Egi, M., & Kondo, Y. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006366 · Cited by 50
C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia
Dell’Anna, A. M., Viotti, J. B., Beumier, M., Orbegozo-Cortès, D., Donadello, K., Scolletta, S., Vincent, J., & Taccone, F. S. (2014) · Resuscitation · doi:10.1016/j.resuscitation.2014.04.003 · Cited by 39
Arulkumaran, N., Khpal, M., Tam, K., Baheerathan, A., Corredor, C., & Singer, M. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004267 · Cited by 36
Luo, G., Zhang, J., Sun, Y., Wang, Y., Wang, H., Cheng, B., Shu, Q., & Fang, X. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00598-3 · Cited by 47
Li, C.-H., Seak, C., Chaou, C., Su, T., Gao, S.-Y., Chien, C., & Ng, C. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-021-06999-4 · Cited by 36
Bakterielle Sepsis: Diagnostik und kalkulierte Antibiotikatherapie
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0363-8 · Cited by 37
Lien, F., Lin, H.-S., Wu, Y.-T., & Chiueh, T. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07223-7 · Cited by 40
Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics
Chaudhry, D., Sharma, A., Govil, D., Hadda, V., Jain, N., Tiwari, P., Samavedam, S., Dixit, S., Govindagoudar, M. B., Khilnani, G. C., et al. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24326 · Cited by 39
Downes, K. J., Weiss, S. L., Gerber, J. S., Klieger, S. B., Fitzgerald, J. C., Balamuth, F., Kubis, S. E., Tolomeo, P., Bilker, W. B., Han, X., et al. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piw023 · Cited by 39
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Bassetti, M., Russo, A., Righi, E., Dolso, E., Merelli, M., D’Aurizio, F., Sartor, A., & Curcio, F. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.06.003 · Cited by 35
Moniz, P., Coelho, L., & Póvoa, P. M. S. R. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01558-w · Cited by 38
The use and risks of antibiotics in critically ill patients
Denny, K. J., Cotta, M. O., Parker, S. L., Roberts, J. A., & Lipman, J. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1164690 · Cited by 33
Goggs, R. A. N., Robbins, S. N., LaLonde‐Paul, D. F., & Menard, J. M. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16374 · Cited by 34
Procalcitonin: present and future
Liu, H. H., Guo, J., Geng, Y., & Su, L. (2015) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-015-1327-0 · Cited by 36
Sepsis Biomarkers. Value and Limitations
Vincent, J., & Teixeira, L. S. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1895ed · Cited by 32
Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
Kyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2022) · Antibiotics · doi:10.3390/antibiotics11030367 · Cited by 38
Duncan, E., Charani, E., Clarkson, J., Francis, J., Gillies, K., Grimshaw, J., Kern, W. V., Lorencatto, F., Marwick, C., McEwen, J., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa001 · Cited by 36
Dias, R. F., de Paula, A. C. R. B., Hasparyk, Ú. G., Coutinho, M. D. O. R. B., Alderete, J. R. A., Kanjongo, J. C., Silva, R. A. M., Guimarães, N. S., Silva, A. C. S. E., & Junior, V. A. N. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08255-3 · Cited by 36
Dyer, E. M., Waterfield, T., & Baynes, H. (2018) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2018-315079 · Cited by 27
Gluck, E. H., Nguyen, H. B., Yalamanchili, K., McCusker, M. E., Madala, J., Corvino, F. A., Zhu, X., & BALK, R. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205924 · Cited by 30
Keir, I., & Dickinson, A. E. (2015) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12272 · Cited by 29
Iskander, K. N., Vaickus, M. H., Duffy, E. R., & Remick, D. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163005 · Cited by 28
Bassetti, M., Russo, A., Righi, E., Dolso, E., Merelli, M., Cannarsa, N., D’Aurizio, F., Sartor, A., & Curcio, F. (2018) · Critical Care · doi:10.1186/s13054-018-2183-x · Cited by 29
Bunduki, G. K., & Adu‐Sarkodie, Y. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05033-1 · Cited by 25
Kataria, Y., & Remick, D. G. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1488-4_16 · Cited by 24
Ali, W. A., Bazan, N. S., Elberry, A. A., & Hussein, R. R. S. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02494-y · Cited by 27
Gutiérrez-Pizarraya, A., León-García, M. D. C., Juan-Idígoras, R. D., & Garnacho‐Montero, J. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1932462 · Cited by 27
Machine learning and synthetic outcome estimation for individualised antimicrobial cessation
Bolton, W., Rawson, T. M., Hernandez, B., Wilson, R. C., Antcliffe, D. B., Georgiou, P., & Holmes, A. H. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.997219 · Cited by 25
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
C–Reactive Protein Kinetics after Cardiac Surgery
Santonocito, C., Sanfilippo, F., Loecker, I. D., Chiarenza, F., Giacomo, C., Njimi, H., George, S., Astuto, M., & Vincent, J. (2022) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_141_21 · Cited by 20
Wang, Z., Huo, B., Wu, Q., Dong, L., Fu, H., Wang, S., & Zhang, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60063-w · Cited by 20
Kim, C.-J. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0172 · Cited by 20
Biomarkers for risk stratification and antibiotic stewardship in elderly patients
Falcone, M., Bauer, M. W., Ferrer, R., Gavazzi, G., del Castillo, J. M. G., Pilotto, A., & Schüetz, P. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02388-w · Cited by 20
Procalcitonin Guided Antibiotic Stewardship
Kiya, G. T., Asefa, E. T., Abebe, G., & Mekonnen, Z. (2024) · Biomarker Insights · doi:10.1177/11772719241298197 · Cited by 25
Profile of the SeptiCyte™ LAB gene expression assay to diagnose infection in critically ill patients
Verboom, D. M., Koster-Brouwer, M. E., Varkila, M. R. J., Bonten, M. J. M., & Cremer, O. L. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1567333 · Cited by 24
Salluh, J. I., Póvoa, P. M. S. R., Beane, A., Kalil, A. C., Sendagire, C., Sweeney, D. A., Pilcher, D. V., Polverino, E., Tacconelli, E., Estenssoro, E., et al. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07381-z · Cited by 21
Use of biomarkers to individualize antimicrobial therapy duration: a narrative review
Scott, J. A., & Deresinski, S. C. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.026 · Cited by 21
Bacterial sepsis: Diagnostics and calculated antibiotic therapy
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0396-z · Cited by 22
Host Response Biomarkers in Sepsis: The Role of Procalcitonin
Vincent, J., Nuffelen, M. V., & Lelubre, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1776-1_16 · Cited by 17
Duijkers, R., Prins, H. J., Kross, M., Snijders, D., van den Berg, J. W., Werkman, G. M., van der Veen, N., Schoorl, M., Bonten, M. J. M., van Werkhoven, C. H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307193 · Cited by 19
Elnajdy, D., & El‐Dahiyat, F. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2037701 · Cited by 15
A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU
Langford, B. J., Beriault, D. R., Schwartz, K. L., Seah, J., Pasic, M. D., Cirone, R., Chan, A. J., & Downing, M. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.02.009 · Cited by 17
Wirz, Y., Branche, A. R., Wolff, M., Welte, T., Junior, V. A. N., Reinhart, K., Falsey, A. R., Damas, P., Beishuizen, A., Deliberato, R. O., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00199 · Cited by 15
Rafiq, S., Shi, C., Ghosal, S., Dark, P. M., Felton, T., Kontopantelis, E., & Dumville, J. C. (2026) · Anaesthesia · doi:10.1111/anae.70109 · Cited by 17
When to Stop Antibiotics in the Critically Ill?
Nielsen, N. D., Dean, J. T., Shald, E. A., Morris, A. C., Póvoa, P. M. S. R., Schouten, J. A., & Parchim, N. F. (2024) · Antibiotics · doi:10.3390/antibiotics13030272 · Cited by 18
Dark, P. M., Perkins, G. D., McMullan, R., McAuley, D. F., Gordon, A. C., Clayton, J., Mistry, D., Young, K., Regan, S. E., McGowan, N., et al. (2023) · Journal of the Intensive Care Society · doi:10.1177/17511437231169193 · Cited by 15
Sartelli, M., Coccolini, F., Labricciosa, F. M., Al‐Hasan, M. N., Buonomo, L. A., Cheadle, W. G., de Simone, B. D., Duane, T. M., Hardcastle, T. C., Hecker, A., et al. (2025) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004833 · Cited by 14
Metadata
- Authors
- Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Venue
- Critical Care Medicine
- Published
- 2013-10
- Volume
- 41
- Issue
- 10
- Pages
- 2336-2343
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2079018559
- Semantic Scholar
- 3891d0cdee5f3e4ad39527256fb686aa6935d02c
- Cited by
- 213
- References
- 38
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 24 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 14 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 1
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universidade Federal de Minas Gerais
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- procalcitonin, C-reactive protein, sepsis, septic shock, antibiotic stewardship, antibiotic duration, biomarkers, intensive care unit patients, bacteremia
- MeSH terms
- Aged, Anti-Bacterial Agents, Brazil, C-Reactive Protein, Calcitonin, Female, Hospitals, University, Humans, Intensive Care Units, Male, Middle Aged, Protein Precursors, Shock, Septic, Biomarkers, Calcitonin Gene-Related Peptide, Confidence Intervals, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.